EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study

Mohamed Abouzid iD, Łukasz Kruszyna iD, Dominika Kaczmarek iD, Leonid Kagan, Aniceta Ada Mikulska-Sauermann iD, Dorota Filipowicz iD, Matylda Resztak iD, Franciszek K Główka iD, Marta Karaźniewicz-Łada iD

Biomolecules · 11.05.2025 · 15 (5) · 699

DOI: 10.3390/biom15050699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 11.05.2025. Verfasst von Mohamed Abouzid und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland. Hauptthemen laut MEDLINE: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase, Cholestanetriol 26-Monooxygenase, Cardiovascular Diseases, Cytochrome P450 Family 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences, Doctoral School of the Poznan University of Medical Sciences, Mohamed Abouzid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The active form of vitamin D, calcitriol (1,25(OH)2D3), is produced from 25(OH)D3 via enzymes encoded by CYP2R1, CYP27A1, and CYP27B1. Polymorphisms in these genes may alter vitamin D metabolism and increase cardiovascular disease risk. This preliminary study investigated these polymorphisms in 27 patients with cardiovascular disease and 26 healthy volunteers using Polymerase Chain Reaction—Restriction Fragment Length Polymorphism (PCR-RFLP), while measuring 25(OH)D3 and 1,25(OH)2D3 concentrations by UPLC-MS/MS and ELISA, respectively. Among patients, those with the GT genotype of rs10877012 (CYP27B1) had higher 25(OH)D3 levels compared to other genotypes. Additionally, this polymorphism was associated with lower 1,25(OH)2D3 in TT homozygotes, suggesting reduced CYP27B1 activity. Furthermore, the TT genotype of rs6709815 (CYP27A1) was three times more prevalent in cardiac patients than in healthy controls, possibly indicating increased susceptibility to the disease. Although these findings suggest a genetic influence on vitamin D metabolism in cardiovascular disease, larger and more comprehensive studies are needed to confirm these associations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

25-Hydroxyvitamin D3 1-alpha-HydroxylaseCholestanetriol 26-MonooxygenaseCardiovascular DiseasesCytochrome P450 Family 2Vitamin DHumansMaleFemalePilot ProjectsMiddle AgedAgedPolymorphism, Single NucleotideGenotypeCase-Control Studies

Stichwörter der Autor:innen

CYP27A1CYP27B1CYP2R1calcidiolcalcitriolcardiovascular disease

Substanzen

25-Hydroxyvitamin D3 1-alpha-HydroxylaseCYP27B1 protein, humanCholestanetriol 26-MonooxygenaseCYP2R1 protein, humanCytochrome P450 Family 2Vitamin DCYP27A1 protein, human

Autor:innen und Institutionen

  • Department of Physical Pharmacy and Pharmacokinetics, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.
  • Doctoral School, Poznan University of Medical Sciences, Bukowska 70, 60-812 Poznan, Poland.
  • Department of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznan University of Medical Sciences, Długa ½, 60-848 Poznan, Poland.
  • Department of Pharmaceutics, Center of Excellence for Pharmaceutical Translational Research and Education, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, Piscataway, NJ 0885, USA.
  • Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 49 Przybyszewskiego Street, 60-355 Poznan, Poland.

ORCID-Profile: Mohamed Abouzid, Łukasz Kruszyna, Dominika Kaczmarek, Aniceta Ada Mikulska-Sauermann, Dorota Filipowicz, Matylda Resztak, Franciszek K Główka, Marta Karaźniewicz-Łada

Förderung

  • Poznan University of Medical Sciences
  • Doctoral School of the Poznan University of Medical Sciences
  • Mohamed Abouzid

Zitieren

APA

Abouzid, M., Kruszyna, Ł., Kaczmarek, D., Kagan, L., Mikulska-Sauermann, A. A., Filipowicz, D., Resztak, M., Główka, F. K., & Karaźniewicz-Łada, M. (2025). Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study. Biomolecules, 15(5), 699. https://doi.org/10.3390/biom15050699

Vancouver

Abouzid M, Kruszyna Ł, Kaczmarek D, Kagan L, Mikulska-Sauermann AA, Filipowicz D, et al. Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study. Biomolecules. 2025;15(5):699. doi:10.3390/biom15050699

BibTeX
@article{Abouzid2025,
  author = {Abouzid, Mohamed and Kruszyna, Łukasz and Kaczmarek, Dominika and Kagan, Leonid and Mikulska-Sauermann, Aniceta Ada and Filipowicz, Dorota and Resztak, Matylda and Główka, Franciszek K and Karaźniewicz-Łada, Marta},
  title = {Genetic Polymorphism of CYP2R1, CYP27A1, CYP27B1, and Vitamin D Metabolites Plasma Levels in Patients with Cardiovascular Disease: A Pilot Study},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {5},
  pages = {699},
  doi = {10.3390/biom15050699}
}
Kostenlos starten →